Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | sphingosine kinase A B | 0.1259 | 0.5 | 0.5 |
Entamoeba histolytica | hypothetical protein, conserved | 0.1259 | 0.5 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.1259 | 0.5 | 0.5 |
Mycobacterium tuberculosis | Conserved protein | 0.1259 | 0.5 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.1259 | 0.5 | 0.5 |
Echinococcus multilocularis | sphingosine kinase 1 | 0.1259 | 0.5 | 0.5 |
Schistosoma mansoni | sphingoid long chain base kinase | 0.1259 | 0.5 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
CC50 (functional) | = 50 ug ml-1 | Cytotoxicity in the Hs 68 cell line | ChEMBL. | 10447945 |
CC50 (functional) | = 50 ug ml-1 | Cytotoxicity in the Hs 68 cell line | ChEMBL. | 10447945 |
IC50 (functional) | = 50 ug ml-1 | Anti-HCMV activity in the human fibroblast Hs 68 cell line | ChEMBL. | 10447945 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.